Skip to main content

ImaGenes Certified for NimbleGen DNA Methylation Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche NimbleGen said today that it has certified Berlin-based genomics services company ImaGenes to offer its DNA Methylation Analysis arrays.

ImaGenes passed the certification to become a Certified Service Provider for the DNA Methylation Analysis workflow, which is used in identifying novel genetic markers that can be used in diagnostic and prognostic development programs.

In December 2009, Roche certified ImaGenes to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services.

This certification makes ImaGenes the first NimbleGen service provider in Europe with multiple certifications, Roche said.

"We are convinced that ImaGenes will further drive the penetration of Roche NimbleGen's innovative products in the functional genomics market," Roche NimbleGen VP of Marketing Andreas Görtz said in a statement.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.